Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogen Sulfide | 11 | 2017 | 39 | 2.390 |
Why?
|
| Aqueous Humor | 6 | 2017 | 18 | 2.160 |
Why?
|
| Cysteine | 7 | 2019 | 98 | 1.240 |
Why?
|
| Ciliary Arteries | 3 | 2018 | 6 | 0.870 |
Why?
|
| Sulfides | 5 | 2017 | 62 | 0.790 |
Why?
|
| Muscle Contraction | 3 | 2018 | 66 | 0.780 |
Why?
|
| Serotonin Antagonists | 2 | 2018 | 23 | 0.780 |
Why?
|
| Ophthalmic Solutions | 2 | 2017 | 18 | 0.770 |
Why?
|
| Trabecular Meshwork | 4 | 2008 | 9 | 0.750 |
Why?
|
| Cyclic AMP | 2 | 2012 | 131 | 0.720 |
Why?
|
| Retina | 6 | 2017 | 280 | 0.690 |
Why?
|
| Anterior Eye Segment | 2 | 2017 | 8 | 0.670 |
Why?
|
| Arachidonic Acids | 2 | 2008 | 24 | 0.640 |
Why?
|
| Ophthalmic Artery | 1 | 2018 | 3 | 0.630 |
Why?
|
| Glycerides | 2 | 2008 | 10 | 0.600 |
Why?
|
| Glaucoma | 2 | 2017 | 85 | 0.600 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2018 | 1039 | 0.540 |
Why?
|
| Iris | 3 | 2010 | 26 | 0.530 |
Why?
|
| Swine | 8 | 2017 | 184 | 0.500 |
Why?
|
| Cattle | 11 | 2019 | 477 | 0.470 |
Why?
|
| Animals | 23 | 2019 | 15081 | 0.420 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2012 | 30 | 0.400 |
Why?
|
| Muscle Relaxation | 2 | 2015 | 19 | 0.400 |
Why?
|
| Muscle, Smooth | 1 | 2010 | 58 | 0.360 |
Why?
|
| Receptor, Cannabinoid, CB1 | 2 | 2008 | 40 | 0.350 |
Why?
|
| Piperidines | 4 | 2015 | 77 | 0.340 |
Why?
|
| Air Pollutants | 1 | 2009 | 94 | 0.320 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2008 | 15 | 0.320 |
Why?
|
| Cystathionine gamma-Lyase | 6 | 2015 | 12 | 0.300 |
Why?
|
| Organothiophosphorus Compounds | 3 | 2016 | 7 | 0.290 |
Why?
|
| Morpholines | 3 | 2016 | 69 | 0.280 |
Why?
|
| Intraocular Pressure | 2 | 2018 | 112 | 0.280 |
Why?
|
| Cystathionine beta-Synthase | 5 | 2015 | 12 | 0.280 |
Why?
|
| Ciliary Body | 3 | 2018 | 23 | 0.270 |
Why?
|
| Organ Culture Techniques | 5 | 2008 | 103 | 0.260 |
Why?
|
| KATP Channels | 4 | 2015 | 11 | 0.250 |
Why?
|
| Pyrazoles | 4 | 2008 | 85 | 0.230 |
Why?
|
| Neurons | 1 | 2009 | 1175 | 0.210 |
Why?
|
| Sympathetic Nervous System | 2 | 2015 | 74 | 0.210 |
Why?
|
| D-Aspartic Acid | 2 | 2011 | 9 | 0.190 |
Why?
|
| Prostaglandins F, Synthetic | 2 | 2016 | 6 | 0.170 |
Why?
|
| Thioctic Acid | 2 | 2016 | 14 | 0.170 |
Why?
|
| Lens, Crystalline | 1 | 2019 | 13 | 0.170 |
Why?
|
| Cataract | 1 | 2019 | 26 | 0.170 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2018 | 5 | 0.160 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 1 | 2018 | 6 | 0.160 |
Why?
|
| Excitatory Amino Acids | 1 | 2017 | 7 | 0.160 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 61 | 0.160 |
Why?
|
| Endocannabinoids | 2 | 2008 | 39 | 0.150 |
Why?
|
| Receptors, Serotonin | 1 | 2018 | 22 | 0.150 |
Why?
|
| Enzyme Inhibitors | 3 | 2015 | 433 | 0.150 |
Why?
|
| Phenylephrine | 2 | 2015 | 36 | 0.150 |
Why?
|
| Receptor, Cannabinoid, CB2 | 2 | 2008 | 32 | 0.140 |
Why?
|
| Flavonoids | 2 | 2008 | 87 | 0.140 |
Why?
|
| Blotting, Western | 3 | 2008 | 859 | 0.140 |
Why?
|
| Prostaglandins | 2 | 2015 | 27 | 0.140 |
Why?
|
| Uvea | 1 | 2015 | 3 | 0.140 |
Why?
|
| Cells, Cultured | 2 | 2012 | 1518 | 0.130 |
Why?
|
| Pyrrolidines | 1 | 2015 | 29 | 0.130 |
Why?
|
| Organophosphorus Compounds | 1 | 2015 | 37 | 0.130 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 245 | 0.130 |
Why?
|
| Isoprostanes | 1 | 2014 | 14 | 0.120 |
Why?
|
| Alkynes | 2 | 2012 | 50 | 0.120 |
Why?
|
| Isometric Contraction | 2 | 2015 | 23 | 0.120 |
Why?
|
| Glycine | 2 | 2012 | 47 | 0.120 |
Why?
|
| Aspartic Acid | 1 | 2014 | 47 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2015 | 130 | 0.120 |
Why?
|
| Blood Pressure | 1 | 2018 | 646 | 0.120 |
Why?
|
| Vasodilation | 1 | 2013 | 65 | 0.110 |
Why?
|
| Carbachol | 2 | 2010 | 19 | 0.110 |
Why?
|
| Receptors, Muscarinic | 2 | 2010 | 18 | 0.110 |
Why?
|
| Neurotransmitter Agents | 2 | 2011 | 63 | 0.110 |
Why?
|
| Aminooxyacetic Acid | 1 | 2012 | 3 | 0.110 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2012 | 30 | 0.100 |
Why?
|
| F2-Isoprostanes | 1 | 2011 | 20 | 0.100 |
Why?
|
| Sus scrofa | 2 | 2008 | 19 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2012 | 444 | 0.090 |
Why?
|
| Eye | 1 | 2011 | 71 | 0.090 |
Why?
|
| Cholinergic Agonists | 1 | 2010 | 7 | 0.090 |
Why?
|
| Glyburide | 1 | 2010 | 8 | 0.090 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2009 | 6 | 0.090 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2009 | 13 | 0.090 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2009 | 34 | 0.090 |
Why?
|
| Muscarinic Antagonists | 1 | 2008 | 12 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2006 | 103 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2006 | 99 | 0.080 |
Why?
|
| Monoacylglycerol Lipases | 1 | 2008 | 2 | 0.080 |
Why?
|
| Amidohydrolases | 1 | 2008 | 11 | 0.080 |
Why?
|
| Chromatography, Thin Layer | 1 | 2008 | 37 | 0.080 |
Why?
|
| Carbamates | 1 | 2008 | 12 | 0.080 |
Why?
|
| Receptors, Cannabinoid | 1 | 2008 | 26 | 0.080 |
Why?
|
| Catecholamines | 1 | 2008 | 44 | 0.080 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2008 | 40 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 252 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2008 | 1908 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2008 | 110 | 0.080 |
Why?
|
| Benzamides | 1 | 2008 | 78 | 0.080 |
Why?
|
| Perfusion | 1 | 2006 | 33 | 0.070 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2006 | 47 | 0.070 |
Why?
|
| Actins | 1 | 2006 | 148 | 0.070 |
Why?
|
| Vasoconstrictor Agents | 2 | 2015 | 41 | 0.060 |
Why?
|
| Rats | 1 | 2012 | 3483 | 0.060 |
Why?
|
| Indoles | 1 | 2005 | 158 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2006 | 928 | 0.060 |
Why?
|
| Norepinephrine | 2 | 2015 | 110 | 0.050 |
Why?
|
| Electric Stimulation | 2 | 2015 | 184 | 0.050 |
Why?
|
| Tritium | 2 | 2011 | 51 | 0.050 |
Why?
|
| Nitric Oxide | 2 | 2015 | 316 | 0.040 |
Why?
|
| Reference Standards | 1 | 2019 | 52 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2019 | 155 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 190 | 0.040 |
Why?
|
| Glutathione | 1 | 2019 | 179 | 0.040 |
Why?
|
| Retinal Diseases | 1 | 2017 | 17 | 0.040 |
Why?
|
| Humans | 2 | 2017 | 37093 | 0.040 |
Why?
|
| Antioxidants | 1 | 2019 | 416 | 0.030 |
Why?
|
| Rabbits | 1 | 2016 | 283 | 0.030 |
Why?
|
| Software Design | 1 | 2015 | 16 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2015 | 146 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2013 | 60 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 938 | 0.030 |
Why?
|
| Potassium Chloride | 1 | 2009 | 28 | 0.020 |
Why?
|
| Miotics | 1 | 2008 | 2 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2005 | 142 | 0.020 |
Why?
|
| Male | 1 | 2016 | 20025 | 0.010 |
Why?
|